Moderate-severe paraprosthetic aortic regurgitation occurred in 10% of TAVI patients and was associated with increased mortality for balloon-expandable, but not self-expanding, devices.
Observational (n=2,440)
Yes
Does the degree of paraprosthetic aortic regurgitation after TAVI predict mortality, and does this association depend on the device type?
Moderate-severe paravalvular aortic regurgitation after TAVI is associated with increased mortality, but this effect may be specific to balloon-expandable rather than self-expanding valves.
OBJECTIVE: The aim of the current study was to identify predictors of paraprosthetic aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) and examine its influence on short/medium-term mortality using the UK TAVI Registry. TAVI is an effective treatment for high-risk patients with severe symptomatic aortic stenosis (AS), but paraprosthetic AR has been associated with increased in-hospital and mid-term mortality. METHODS: Between January 2007 and December 2011, 2584 TAVI procedures were performed in the UK. Patients undergoing 'valve-in-valve' procedures, patients with aortic regurgitation as the primary pathology and with no recorded severity of AR were excluded from this analysis (n=144). In total, therefore, 2440 patients were included. Balloon-expandable and self-expanding devices were implanted in 52.7 and 47.2%, respectively, using either transfemoral (67.7%) or non-transfemoral, surgical access (32.3%). RESULTS: Postprocedural AR was observed in 68%, mild AR in 57% and moderate-severe in 10%. A large aortic annulus, high preprocedural transaortic gradient, and use of self-expanding valve were independent predictors of moderate-severe AR. Moderate-severe (but not mild) AR was associated with increased mortality, and this relationship appeared significant for the balloon-expandable but not the self-expanding device. CONCLUSIONS: Our data suggest that a large aortic annulus, high preprocedural transaortic gradient, and use of the self-expanding valve predict moderate-severe AR after TAVI. Such a degree of AR is associated with a significantly worse outcome with the balloon-expandable, but not with the self-expanding valve. Further studies are needed to verify this and explore potential mechanisms.
Dworakowski et al. (Tue,) conducted a observational in severe symptomatic aortic stenosis (n=2,440). Transcatheter aortic valve implantation (TAVI) was evaluated on Predictors of paraprosthetic aortic regurgitation and its influence on short/medium-term mortality. Moderate-severe paraprosthetic aortic regurgitation occurred in 10% of TAVI patients and was associated with increased mortality for balloon-expandable, but not self-expanding, devices.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: